Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-02-07
DOI
10.1038/srep04026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium
- (2013) M. Kobel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Keeping it simple: Genetics referrals for all invasive serous ovarian cancers
- (2013) R. Demsky et al. GYNECOLOGIC ONCOLOGY
- Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
- (2013) Mine S. Cicek et al. HUMAN MOLECULAR GENETICS
- GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
- (2013) Paul D P Pharoah et al. NATURE GENETICS
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
- (2013) Stig E Bojesen et al. NATURE GENETICS
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- (2013) Jennifer Permuth-Wey et al. Nature Communications
- Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
- (2013) Hui Shen et al. Nature Communications
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
- (2012) V Abkevich et al. BRITISH JOURNAL OF CANCER
- GermlineRAD51Cmutations in ovarian cancer susceptibility
- (2012) F Coulet et al. CLINICAL GENETICS
- The Role of PARP Inhibitors in the Treatment of Ovarian Carcinomas
- (2012) Anna V. Tinker et al. CURRENT PHARMACEUTICAL DESIGN
- Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer
- (2012) T. Hansmann et al. HUMAN MOLECULAR GENETICS
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
- (2012) John R. McLaughlin et al. JNCI-Journal of the National Cancer Institute
- Germline RAD51C mutations confer susceptibility to ovarian cancer
- (2012) Chey Loveday et al. NATURE GENETICS
- BRCAness: Finding the Achilles Heel in Ovarian Cancer
- (2012) G. Rigakos et al. ONCOLOGIST
- Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival
- (2012) Joyce Liu et al. Cancer Genetics
- SomaticSniper: identification of somatic point mutations in whole genome sequencing data
- (2011) David E. Larson et al. BIOINFORMATICS
- TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data
- (2011) Yan W. Asmann et al. BIOINFORMATICS
- Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality
- (2011) E. L. Goode et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Germline mutations in RAD51D confer susceptibility to ovarian cancer
- (2011) Chey Loveday et al. NATURE GENETICS
- RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
- (2011) Jessica Clague et al. PLoS One
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Methylation profiles of hereditary and sporadic ovarian cancer
- (2010) Guus M Bol et al. HISTOPATHOLOGY
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
- (2010) Ellen L Goode et al. NATURE GENETICS
- Common variants at 19p13 are associated with susceptibility to ovarian cancer
- (2010) Kelly L Bolton et al. NATURE GENETICS
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
- (2009) Susan J. Ramus et al. Molecular Oncology
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
- (2009) Honglin Song et al. NATURE GENETICS
- “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations
- (2008) David S.P. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started